(MENAFN- GlobeNewsWire - Nasdaq) CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that third quarter of fiscal year 2025 financial results will be reported after the market closes on Thursday, November 6th.

Management will host a conference call at 5:00 p.m. Eastern Time on November 6th to discuss the results of the quarter, and to provide a corporate update with a question and answer session. Those who would like to participate may access the live webcast here , or access the teleconference by dialing 800-715-9871 (646-307-1963 for international callers) and providing access code : 9073428. The live webcast can also be accessed via the company's website at organogenesis . The webcast will be archived on the company website for approximately one year.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit .

CONTACT: Investor Inquiries: ICR Healthcare Mike Piccinino, CFA ... Press and Media Inquiries: Organogenesis ...

MENAFN01102025004107003653ID1110139047